An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines - PubMed (original) (raw)
An autocrine role for urokinase in phorbol ester-mediated differentiation of myeloid cell lines
A R Nusrat et al. J Clin Invest. 1991 Mar.
Abstract
The human myeloid cell line HL60 secretes urokinase-type plasminogen activator (uPA) and expresses its receptor. When stimulated with phorbol myristate acetate (PMA), both secretion of uPA and the expression of its receptor are up-regulated, and these cells differentiate to an adherent phenotype. This adhesive response is markedly reduced in the presence of uPA antibodies. The PMA response is restored by the addition of native uPA, an amino-terminal fragment of uPA (residues 1-143) devoid of proteolytic activity, or a synthetic peptide (residues 12-32) from the uPA growth factor domain known to mediate receptor binding. In contrast, the addition of catalytically active low molecular weight uPA, which is missing the growth factor domain, or a peptide from the catalytic domain (residues 247-266) is ineffective. The influence of uPA antibodies on a second marker of macrophage differentiation, cysteine proteinase activity, was also examined. Cysteine proteinase activity of HL60 cells is increased in PMA-treated cells after 24 h but it fails to increase in the presence of anti-uPA. This increase in cathepsin B-like activity is also restored by exogenous uPA. These experiments indicate that an autocrine interaction of the growth factor domain of uPA with its receptor mediates an essential step in PMA-mediated myeloid cell differentiation.
Similar articles
- Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
Picone R, Kajtaniak EL, Nielsen LS, Behrendt N, Mastronicola MR, Cubellis MV, Stoppelli MP, Pedersen S, Danø K, Blasi F. Picone R, et al. J Cell Biol. 1989 Feb;108(2):693-702. doi: 10.1083/jcb.108.2.693. J Cell Biol. 1989. PMID: 2537321 Free PMC article. - Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors.
Waltz DA, Sailor LZ, Chapman HA. Waltz DA, et al. J Clin Invest. 1993 Apr;91(4):1541-52. doi: 10.1172/JCI116360. J Clin Invest. 1993. PMID: 8386190 Free PMC article. - THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ, McCaffrey TA, Mathew J, McAdam K, Borth W. Falcone DJ, et al. J Cell Physiol. 1995 Aug;164(2):334-43. doi: 10.1002/jcp.1041640214. J Cell Physiol. 1995. PMID: 7622580 - Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T, Behrendt N, Ploug M. Plesner T, et al. Stem Cells. 1997;15(6):398-408. doi: 10.1002/stem.150398. Stem Cells. 1997. PMID: 9402652 Review. - The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis.
Alfano D, Franco P, Vocca I, Gambi N, Pisa V, Mancini A, Caputi M, Carriero MV, Iaccarino I, Stoppelli MP. Alfano D, et al. Thromb Haemost. 2005 Feb;93(2):205-11. doi: 10.1160/TH04-09-0592. Thromb Haemost. 2005. PMID: 15711734 Review.
Cited by
- Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation.
Zaitsev S, Spitzer D, Murciano JC, Ding BS, Tliba S, Kowalska MA, Marcos-Contreras OA, Kuo A, Stepanova V, Atkinson JP, Poncz M, Cines DB, Muzykantov VR. Zaitsev S, et al. Blood. 2010 Jun 24;115(25):5241-8. doi: 10.1182/blood-2010-01-261610. Epub 2010 Apr 21. Blood. 2010. PMID: 20410503 Free PMC article. - Macrophage-dependent cleavage of the laminin receptor α6β1 in prostate cancer.
Sroka IC, Sandoval CP, Chopra H, Gard JM, Pawar SC, Cress AE. Sroka IC, et al. Mol Cancer Res. 2011 Oct;9(10):1319-28. doi: 10.1158/1541-7786.MCR-11-0080. Epub 2011 Aug 8. Mol Cancer Res. 2011. PMID: 21824975 Free PMC article. - PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophages.
Ballonová L, Kulíšková P, Slanina P, Štíchová J, Vlková M, Hakl R, Litzman J, Souček P, Freiberger T. Ballonová L, et al. Mol Biol Rep. 2023 Jun;50(6):4975-4982. doi: 10.1007/s11033-023-08391-8. Epub 2023 Apr 22. Mol Biol Rep. 2023. PMID: 37086298 - Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication.
Alfano M, Sidenius N, Panzeri B, Blasi F, Poli G. Alfano M, et al. Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8862-7. doi: 10.1073/pnas.142078099. Proc Natl Acad Sci U S A. 2002. PMID: 12084931 Free PMC article. - Generation and characterization of urokinase receptor-deficient mice.
Dewerchin M, Nuffelen AV, Wallays G, Bouché A, Moons L, Carmeliet P, Mulligan RC, Collen D. Dewerchin M, et al. J Clin Invest. 1996 Feb 1;97(3):870-8. doi: 10.1172/JCI118489. J Clin Invest. 1996. PMID: 8609247 Free PMC article.
References
- J Cell Biol. 1988 Dec;107(6 Pt 1):2437-45 - PubMed
- J Clin Invest. 1988 Dec;82(6):1992-2000 - PubMed
- FASEB J. 1987 Aug;1(2):125-8 - PubMed
- J Biol Chem. 1987 Apr 5;262(10):4437-40 - PubMed
- Biochem Biophys Res Commun. 1987 Sep 30;147(3):1176-81 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous